Manuscripts
Showing 1591 manuscripts.
Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth
Citation
Anne M. Neilan, Brad Karalius, Kunjal Patel, Russell B. Van Dyke, Mark J. Abzug, Allison L. Agwu, Paige L. Williams, Murli Purswani, Deborah Kacanek, James M. Oleske, Sandra K. Burchett, Andrew Wiznia, Miriam Chernoff, George R. Seage III, Andrea L. Ciaranello, Pediatric HIV/AIDS Cohort Study and the International Maternal Adolescent and Pediatric AIDS Clinical Trials Network. Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth. The Journal of the American Medical Association. 2017 May 01; 171(5):450-460. PMID: 28346597; PMCID: PMC5411314.Year
2017
Journal
The Journal of the American Medical Association
Study
P1074
Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 = 400 cells/mm3
Citation
Judith S Currier, Paula Britto, Risa M Hoffman, Sean Brummel, Gaerolwe Masheto, Esau Joao, Breno Santos, Linda Aurpibul, Marcelo Losso, Marie F Pierre, Adriana Weinberg, Devasena Gnanashanmugam, Nahida Chakhtoura, Karin Klingman, Renee Browning, Anne Coletti, Lynne Mofenson, David Shapiro, Jose Pilotto, 1077HS PROMISE Team. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 = 400 cells/mm3. PLoS One. 2017 May 10; 12(5):e0176009. PMID: 28489856; PMCID: PMC5425014.Year
2017
Journal
PLoS One
Study
1077HS
Four-Year Persistence of Type-Specific Immunity After Quadrivalent
Human Papillomavirus Vaccination in HIV-infected Children: Effect of a
Fourth Dose of Vaccine
Citation
Myron j Levin, Sharon Huang, Anna-Barbara Moscicki, Lin-Ye Song, Jennifer S Read, William A Meyer III, Alfred J Saah, Kelly Richardson, Adriana Weinberg. Four-Year Persistence of Type-Specific Immunity After Quadrivalent Human Papillomavirus Vaccination in HIV-infected Children: Effect of a Fourth Dose of Vaccine. Vaccine. 2017 Mar 23; 35(13):1712-1720. PMID: 28238631; PMCID: PMC5665177.Year
2017
Journal
Vaccine
Study
P1085
Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057
Citation
Luiz Eduardo Osorio, Maria Ines Boechat, Mark Mirochnick, Newton Kumwenda, Regis Kreitchmann, Lynda Emel, Jorge Pinto, Esau Joao, Breno Santos, Molly Swenson, Kathleen George, Paul Sato, Lynne Mofenson, Karin Nielsen-Saines. Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057. Pediaric Infectious Disease Journal. 2017 Feb 16; 36(2):184-188. PMID: 27798550; PMCID: PMC5233548.Year
2017
Journal
Pediaric Infectious Disease Journal
Delay in sexual maturation in perinatally HIV-infected youth are mediated by poor growth
Citation
A Bellavia, PL Williams, LA DiMeglio, R Hazra, M Abzug, K Patel, DL Jacobson, R Van Dyke, ME Geffner. Delay in sexual maturation in perinatally HIV-infected youth are mediated by poor growth. AIDS. 2017 Jun 01; 31(9):1333-1341. PMID: 28358737; PMCID: PMC5472204.Year
2017
Journal
AIDS
Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol
Citation
Jennifer Jao, Deborah Kacanek, Paige L Williams, Mitchell E Geffner, Elizabeth G Livingston, Rhonda S Sperling, Kunjal Patel, Arlene D Bardequez, Sandra K Burchett, Nahida Chakhtoura, Gwendolyn B Scott, Russell B Van Dyke, Elaine J Abrams, Pediatric HIV/AIDS Cohort Study and the International Maternal Pediatric Adolescent AIDS Clinical Trials P1025 Protocol. Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol. Clinical Infectious Diseases. 2017 Sep 15; 65(6):982-989. PMID: 28575201; PMCID: PMC5849107.Year
2017
Journal
Clinical Infectious Diseases
Study
P1025
Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
Citation
AL Agwu, MG Warshaw, EJ McFarland, GK Siberry, AJ Melvin, AA Wiznia, L Fairlie, S Boyd, P Harding, HML Spiegel, EJ Abrams, VJ Carey, P1094 Study Team. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial. PLoS One. 2017 Jun 12; 12(6):e0178075. PMID: 28604824; PMCID: PMC5467803.Year
2017
Journal
PLoS One
Study
P1094
Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital
Cytomegalovirus Infection
Citation
K Adachi, J Xu, B Ank, DH Watts, LM Mofenson, JH Pilotto, E Joao, B Santos, R Fonseca, R Kreitchmann, J Pinto, MM Mussi-Pinhata, G Gray, G Theron, MG Morgado, YJ Bryson, VG Veloso, JD Klausner, J Move, K Nielsen-Saines, NICHD HPTN 040. Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection. Clinical Infectious Diseases. 2017 Aug 01; 65(3):405-413. PMID: 28369278.Year
2017
Journal
Clinical Infectious Diseases
Study
P1043/HPTN 040
Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8Tscm Cells in Children with HIV Receiving Raltegravir
Citation
F Tuluc, S Spitsin, NB Tustin, JB Murray, R Tustin 3rd, LA Schankel, A Wiznia, S Nachman, SD Douglas. Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8Tscm Cells in Children with HIV Receiving Raltegravir. AIDS Research and Human Retroviruses. 2017 Feb 25; 33(2):133-142. PMID: 27615375; PMCID: PMC5312622.Year
2017
Journal
AIDS Research and Human Retroviruses
Study
P1066
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection
Citation
C Bolton Moore, EV Capparelli, P Samson, M Bwakura-Dangarembizi, P Jean-Philippe, C Worrell, B Heckman, L Purdue, SA Spector, A Benns, W Borkowsky, A Loftis, E Hawkins, C Wallis, EG Chadwick, IMPAACT P1070 team. CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection. AIDS. 2017 May 15; 31(8):1129-1136. PMID: 28323755; PMCID: PMC5623109.Year
2017
Journal
AIDS
Study
P1070